Editor-in-Chief of Research and Reports in Medicinal Chemistry
Dove Medical Press announces Dr Xing-Cong Li as the Editor-in-Chief of Research and Reports in Medicinal Chemistry
Auckland, New Zealand (PRWEB) July 09, 2011
Dove Medical Press has announced the appointment of Dr Xing-Cong Li as the Editor-in-Chief of the new journal Research and Reports in Medicinal Chemistry.
This international, peer-reviewed open access journal will publish original research, reports, reviews and commentaries on all areas of medicinal chemistry.
Dr Li is a Senior Scientist in the National Center for Natural Products Research (NCNPR) and a Research Associate Professor in the Department of Pharmacognosy at the University of Mississippi, USA. His research interests include isolation, structure elucidation, and synthesis of bioactive natural products, medicinal plant research, and natural products based drug design. In particular, his current research focuses on the discovery of antifungal natural products that can be used as molecular probes to uncover novel drug targets or lead to the development of new antifungal drugs for the treatment of life-threatening opportunistic fungal infections. Dr Li has also published more than 100 peer-reviewed journal articles/book chapters in the field of natural product and medicinal chemistry.
He says, "Medicinal Chemistry is an important discipline that has significantly contributed to human wellness. Over the past two decades, the emerging cutting-edge technologies in the fields of chemistry, biology, and computational chemistry have made it possible to discover new medicines to treat or prevent human diseases. Our newly launched journal has opened an avenue for medicinal chemists to publish their research in a timely fashion."
Publisher Tim Hill at Dove Medical Press added, "The appointment of Dr Li as the Editor-in-Chief of Research and Reports in Medicinal Chemistry is particularly exciting at this time, with the heightened level of interest in this field internationally. All of us at Dove Medical Press are committed to sustaining the highest levels of editorial integrity, rigorous and constructive peer-review, along with rapid publication times and the presentation of quality research findings."
Dove Medical Press is a privately held publisher of 100+ open access peer-reviewed journals across the broad spectrum of science, technology and especially medicine. Dove was founded in 2003 and has offices in the United Kingdom and New Zealand, with an active presence in the USA and a network of agents in Europe, the Americas, and Southeast Asia.
Dove Medical Press Ltd
Angela Jones, +64-9-476 6466
Updated 23 July 2014